Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial

BACKGROUND: Vitamin D (VD) may increase sirtuin 1 (SIRT1) and subsequently PPAR-γ coactivator 1α (PGC-1α) and irisin levels and these improvements may reduce insulin resistance (IR). The aim was to assess the effects of vitamin D supplementation on SIRT1, irisin, and IR in overweight/obese type 2 di...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Fam Pract
Auteurs principaux: Safarpour, Peivasteh, Daneshi-Maskooni, Milad, Vafa, Mohammadreza, Nourbakhsh, Mitra, Janani, Leila, Maddah, Mohsen, Amiri, Fatemeh-Sadat, Mohammadi, Fereshteh, Sadeghi, Homa
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007689/
https://ncbi.nlm.nih.gov/pubmed/32033527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12875-020-1096-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires